VONOPRAZAN 3 WEEKS TREATMENT IS NOT INFERIOR TO 8 WEEKS TREATMENT FOR THE MANAGEMENT AFTER GASTRIC ESD: A MULTICENTER RANDOMIZED NON-INFERIORITY STUDY
Mizuki Kuramochi 1
Motohiko Kato 2
Naoki Hosoe 2
Takuji Gotoda 3
Chika Kusano 4
Hideo Yoshida 5
Yoshiaki Kimoto 6
Yukishige Okamura 7
Hiroyuki Imaeda 8
Takafumi Ito 9
Yasuo Miyamoto 10
Toshiki Horii 10
Hideki Mori 11
Yuichi Morohoshi 12
Akiko Ohno 13
Ryohei Kishino 14
Yoko Kubosawa 14
Kenichi Yoshimura 15
Naohisa Yahagi 15
Takanori Kanai 15
1 National Hospital Organization Saitama Hospital, Saitama, Japan
2 Keio University School of Medicine, Tokyo, Japan
3 Nihon University School of Medicine, Tokyo, Japan
4 Kitasato University School of Medicine, Kanagawa, Japan
5 Eiju General Hospital, Tokyo, Japan
6 NTT Medical Center, Tokyo, Japan
7 Sano Kosei Gneral Hospital, Tochigi, Japan
8 Saitama Medical University Hospital, Saitama, Japan
9 Keiyu Hospital, Yokohama, Japan
10 Kitasato University, Kitasato Institute Hospital, Tokyo, Japan
11 National Hospital Organization Tokyo Medical Center, Tokyo, Japan
12 Yokohama Municipal Citizen’s Hospital, Yokohama, Japan
13 Kyorin University School of Medicine, Tokyo, Japan
14 Saiseikai Central Hospital, Tokyo, Japan
15 Future Medical Center, Hiroshima University Hospital, Hiroshima, Japan
Topic
Digestive Oncology, Endoscopy, Oesophagus, Stomach & H. Pylori
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]